Peter Cole is an Oncology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
195 Little Albany St
New Brunswick, NJ 08901
Telephone
732-235-8864Provider last certified this registry record 11 Apr 2024.
Clinical trials
- Supraclavicular Nerve During Clavicle ORIF
Sponsor: HealthPartners Institute
- North American Scapula Consortium
Sponsor: North American Scapula Consortium
- The Effect of Timing of Removal of Wound Dressing on Surgical Site Infection Rate After Cesarean Delivery
Sponsor: Albany Medical College
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RARE DISEASE THERAPEUTICS, INC.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20221 payment
- Servier Pharmaceuticals LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Identification of novel biomarkers and therapeutic strategies in chemobrain.
Rutgers Biomedical and Health Sciences
FY2026$1,777,449R01CA293210 - Metformin to prevent chemotherapy-induced neurotoxicity among children with leukemia
Rutgers Biomedical and Health Sciences
FY2026$600,871R01CA316157 - Identification of novel biomarkers and therapeutic strategies in chemobrain.
Rutgers Biomedical and Health Sciences
FY2025$593,672R01CA293210
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”